Program to reduce opioid use in chronic pain patients after surgery
Ontario Transitional Pain and Opioid Safety Program: Improving Pain and Opioid Practices for Complex Chronic Pain Patients Following Surgery
This study is testing a new program to help chronic pain patients use less opioids after surgery by providing pain education and support tools.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 210 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT03675386 on ClinicalTrials.gov |
What this trial studies
This program aims to help chronic pain patients who are prescribed opioids manage their pain more effectively and reduce their reliance on these medications following surgery. The Toronto General Hospital has developed a multidisciplinary Transitional Pain Service Program (TPSP) that includes pain education, Acceptance and Commitment Therapy (ACT), and an e-mobile self-management tool. A multicenter randomized controlled trial will evaluate the effectiveness of the TPSP across six hospital sites in Ontario, targeting 210 patients currently using opioids. The study will also analyze healthcare utilization and gather qualitative insights from participants to inform future pain management policies.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are taking 20 to 200 mg of oral morphine equivalents daily and are scheduled for a surgical procedure.
Not a fit: Patients undergoing palliative care, organ transplantation, or those prescribed Methadone/Buprenorphine may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly reduce opioid dependence and improve pain management for patients after surgery.
How similar studies have performed: Other studies have shown promise in similar approaches to opioid reduction and pain management, but this specific program is novel in its comprehensive multidisciplinary approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 18 years of age * Taking 10 -- 400 mg of preoperative oral morphine equivalents daily * Any type of surgical procedure, with the exception of those with palliative intent or organ transplantation * Able to read and understand English as posed on the questionnaire surveys prior to informed consent * Must be taking opioids for at least one month prior to their operation * Must have a personal email address for the set-up of the Manage My Pain (MMP) App or online multimedia tool Exclusion Criteria: • Subjects who are undergoing palliative care or procedures, organ transplantation, or prescribed with Methadone/Buprenorphine will be excluded from the trial
Where this trial is running
Toronto, Ontario
- Toronto General Hospital- University Health Network — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Karim Ladha, MD — Toronto General Hospital, University Health Network
- Study coordinator: Karim Ladha, MD
- Email: Karim.Ladha@uhn.ca
- Phone: 416-719-0030
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.